Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 13 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 11337988

    Use of ouabain antagonists to inhibit viral infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 24, 2022 · Expires May 19, 2042

    granted

  2. US 11338032

    Methods of preparing anti-human papillomavirus antigen T cells

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted May 24, 2022 · Expires May 19, 2042

    granted

  3. US 11339387

    Modified foot-and-mouth disease virus 3C proteases and methods for processing FMDV P1 precursor polypeptide

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted May 24, 2022 · Expires May 19, 2042

    granted

  4. US 11339198

    Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 24, 2022 · Expires May 19, 2042

    granted

  5. US 11338033

    Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 24, 2022 · Expires May 19, 2042

    granted

  6. US 11337971

    Dopamine D3 receptor selective antagonists/partial agonists and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 24, 2022 · Expires May 19, 2042

    granted

  7. US 11332721

    Recombinant respiratory syncytial virus strains with mutations in the M2-2 ORF providing a range of attenuation phenotypes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 17, 2022 · Expires May 12, 2042

    granted

  8. US 11331370

    Combination product for the prevention of sexually transmitted infections

    The United States of America · Granted May 17, 2022 · Expires May 12, 2042

    granted

  9. US 11331385

    Methods of preparing anti-human papillomavirus antigen T cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 17, 2022 · Expires May 12, 2042

    granted

  10. US 11332722

    Development of dengue virus vaccine components

    The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted May 17, 2022 · Expires May 12, 2042

    granted

  11. US 11325965

    Single-domain VH H antibodies directed to norovirus GI.1 and GII.4 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 10, 2022 · Expires May 5, 2042

    granted

  12. US 11325978

    Compositions and methods for treating beta-globinopathies

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 10, 2022 · Expires May 5, 2042

    granted

  13. US 11324725

    Compositions and methods for the inhibition of pruritus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 10, 2022 · Expires May 5, 2042

    granted

  14. US 11318196

    Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural protein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 3, 2022 · Expires Apr 28, 2042

    granted

  15. US 11311613

    Development of agonist epitopes of the human papillomavirus

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Apr 26, 2022 · Expires Apr 21, 2042

    granted

  16. US 11306131

    T cell receptors recognizing HLA-A1- or HLA-CW7-restricted mage

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted

  17. US 11306132

    HLA class II-restricted T cell receptors against mutated RAS

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted

  18. US 11305009

    Recombinant virus with diminished latency and methods of using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted

  19. US 11299517

    Recombinant vaccine against Marek's disease and Newcastle disease

    The United States of America, as represented by the Secretary of Agriculture · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  20. US 11299546

    FLT3-specific chimeric antigen receptors and methods using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  21. US 11299476

    Dopamine D3 receptor selective antagonists/partial agonists; method of making; and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  22. US 11293010

    Methods of producing modified natural killer cells and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 5, 2022 · Expires Mar 31, 2042

    granted

  23. US 11285169

    Methods for modulating chemotherapeutic cytotoxicity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted

  24. US 11285142

    Compositions and methods for identifying and treating dystonia disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.